0
Original Article | ONLINE FIRST

Increased von Willebrand Factor to ADAMTS13 Ratio as a Predictor of Thrombotic Complications Following a Major Hepatectomy

Shin-ichiro Kobayashi, MD; Yukihiro Yokoyama, MD; Tadashi Matsushita, MD; Motoshi Kainuma, MD; Tomoki Ebata, MD; Tsuyoshi Igami, MD; Gen Sugawara, MD; Yu Takahashi, MD; Masato Nagino, MD
Arch Surg. 2012;147(10):909-917. doi:10.1001/archsurg.2012.998.
Text Size: A A A
Published online

Objective  To investigate the association between changes in procoagulant/fibrinolytic factors and thrombotic complications following a major hepatectomy. Little information is available regarding the changes in procoagulant/fibrinolytic factors (such as the von Willebrand factor [vWF] and a disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13 [ADAMTS13]), following a major hepatectomy.

Design  Patients who underwent a major hepatectomy from 2010 to 2011 were enrolled. Patients who underwent a pancreatoduodenectomy (PD) during the same period were also observed as controls, for whom operation time and amount of intraoperative blood loss were comparable to those of the patients who underwent a major hepatectomy. Blood samples were prospectively collected to measure various procoagulant/fibrinolytic factors, including vWF and ADAMTS13.

Setting  Nagoya University Hospital, Japan.

Patients  A total of 50 patients who underwent a major hepatectomy and a total of 23 patients who underwent a PD.

Results  The levels of vWF in the patients who underwent a major hepatectomy increased from before the operation to the seventh postoperative day and were significantly higher than those observed in the patients who underwent a PD. The ADAMTS13 activity in the patients who underwent a major hepatectomy gradually decreased throughout the first 14 postoperative days. In contrast, ADAMTS13 activity in the patients who underwent a PD returned to nearly normal levels within 2 weeks. Three patients who underwent a major hepatectomy had clinically significant thrombotic complications within the first 2 weeks after surgery; however, none of the patients who underwent a PD had thrombotic complications. The vWF to ADAMTS13 ratios of the 3 patients who experienced thrombotic complications were extremely high even before the occurrence of complications. No other procoagulant/fibrinolytic factors showed a marked association with thrombotic events. The vWF to ADAMTS13 ratio was significantly correlated with the estimated liver remnant volume (P < .001) but not with other preoperative or intraoperative factors.

Conclusions  The vWF to ADAMTS13 ratio may be a potentially useful marker in predicting thrombotic complications following a major hepatectomy.

Figures in this Article

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Place holder to copy figure label and caption
Grahic Jump Location

Figure 1. Changes in procoagulant and fibrinolytic factors (A-G) in patients before and after a major hepatectomy (filled circles) or a pancreatoduodenectomy (open squares). Values are expressed as mean values. Error bars indicate SD. * P < .05. APTT indicates activated partial thromboplastin time; PIC, plasmin-α2 plasmin inhibitor complex; POD, postoperative day; PT, prothrombin time; TAT, thrombin-antithrombin III complex.

Place holder to copy figure label and caption
Grahic Jump Location

Figure 2. Changes in the plasma von Willebrand factor (vWF) antigen level (A), ADAMTS13 (a disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13) activity (B), and the vWF to ADAMTS13 ratio (C) in patients before and after a major hepatectomy (filled circles) or a pancreatoduodenectomy (open squares). Values are expressed as mean values. Error bars indicate SD. * P < .05. POD indicates postoperative day.

Place holder to copy figure label and caption
Grahic Jump Location

Figure 3. Changes in the plasma von Willebrand factor (vWF) antigen level (A), ADAMTS13 (a disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13) activity (B), and the vWF to ADAMTS13 ratio (C) in patients before and after a major hepatectomy without pancreatoduodenectomy (filled circles) or a major hepatectomy with pancreatoduodenectomy (open triangles). Values are expressed as mean values. Error bars indicate SD. * P < .05. POD indicates postoperative day.

Place holder to copy figure label and caption
Grahic Jump Location

Figure 4. Changes in the von Willebrand factor (vWF) to ADAMTS13 (a disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13) ratio in 3 cases with clinically significant thrombotic complications (cases A [open circles], B [open squares], and C [open triangles]). The arrows indicate the postoperative day (POD) that thrombotic complications occurred. The dotted line indicates the mean value for cases without thrombotic complications.

Place holder to copy figure label and caption
Grahic Jump Location

Figure 5. Correlations between the von Willebrand factor (vWF) to ADAMTS13 (a disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13) ratio and indocyanine green (ICG) retention rate at 15 minutes (A), the vWF to ADAMTS13 ratio and operation time (B), the vWF to ADAMTS13 ratio and intraoperative blood loss (C), and the vWF to ADAMTS13 ratio and remnant liver volume (D), on postoperative day 7 in 50 patients who underwent a major hepatectomy (filled diamonds). The open diamonds indicate patients with thrombotic complications.

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 1

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
Jobs